metricas
covid
Buscar en
Revista Colombiana de Reumatología
Toda la web
Inicio Revista Colombiana de Reumatología Lupus Eritematoso Sistémico Ampolloso: dramática respuesta a la terapia con da...
Journal Information
Vol. 16. Issue 4.
Pages 352-360 (December 2009)
Share
Share
Download PDF
More article options
Vol. 16. Issue 4.
Pages 352-360 (December 2009)
Full text access
Lupus Eritematoso Sistémico Ampolloso: dramática respuesta a la terapia con dapsona
Bullous Systemic Lupus Erythematosus: dramatic response to dapsone
Visits
10464
Luis Alonso González1, Mauricio Restrepo1, Gloria Vásquez1,2
1 Profesores, Sección de Reumatología, Departamento de Medicina Interna, Facultad de Medicina, Universidad de Antioquia, Hospital Universitario San Vicente de Paúl, Medellín, Colombia
2 Grupos de Inmunología celular e inmunogenética. Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia. E-mail
This item has received
Article information
Resumen

El lupus ampolloso es una manifestación poco frecuente del lupus eritematoso sistémico (LES). Otras enfermedades ampollosas tales como el penfigoide ampolloso, epidermólisis ampollosa adquirida, dermatosis ampollosa Ig A lineal y dermatitis herpetiforme también han sido informadas en LES. Describimos un paciente que desarrolló lesiones ampollosas 14 días luego de iniciar terapia con altas dosis de glucocorticoides y ciclofosfamida para manifestaciones severas del LES (nefritis y hemorragia alveolar). Se confirmó el diagnóstico de lupus ampolloso. La respuesta al tratamiento con dapsona fue notable a las 48 horas. En este artículo revisamos la epidemiología, hallazgos clínicos, histopatológicos e inmunopatológicos; el diagnóstico diferencial y el tratamiento del LES ampolloso.

Palabras clave:
lupus eritematoso sistémico ampolloso
dapsona
lupus cutáneo
Summary

Bullous systemic lupus erythematosus (BSLE) is an unusual finding in systemic lupus erythematosus (SLE). Other bullous disorders such as bullous pemphigoid, epirdermolysis bullosa acquisita, linear IgA bullous dermatosis and dermatitis herpetiformis has also been reported in association with SLE. We described a patient who developed severe bullous lesions 14 days after high-dose systemic glucocorticoids and cyclophosphide therapies were initiated for severe SLE manifestations (nephritis and alveolar hemorrhage). A diagnosis of bullous SLE was made. Therapy with dapsone resulted in a marked clinical improvement of the bullous eruption within 48 hours. This article also discusses the epidemiology, clinical, histopathologic and immunopathologic features, differential diagnosis and the treatment of BSLE.

Key words:
bullous systemic lupus erythematosus
dapsone
cutaneous lupus
Full text is only aviable in PDF
Referencias
[1.]
M. Petri.
Dermatologic lupus.
Sem Cut Med Surg, 17 (1998), pp. 219-227
[2.]
M. Pistiner, D.J. Wallace, S. Nessim, et al.
Lupus erythematosus in the 1980s: a survey of 570 patients.
Semin Arthritis Rheum, 21 (1991), pp. 55-64
[3.]
J.N. Gilliam, R.D. Sontheimer.
Skin manifestations of SLE.
Clin Rheum Dis, 8 (1982), pp. 207-218
[4.]
M.I. Costner, R.D. Sontheimer.
Lupus-Nonspecific Skin Disease.
Dubois’ Lupus Erythematosus, 7th, pp. 621-636
[5.]
W.R. Gammon, R.A. Briggaman.
Bullous SLE: a phenotypically distinctive but immunologically heterogeneous bullous disorder.
J Invest Dermatol, 100 (1993), pp. 28S-34S
[6.]
N.P. Burrows, B.S. Bhogal, M.M. Black, et al.
Bullous eruption of systemic lupus erythematosus: a clinicopathological study of four cases.
Br J Dermatol, 128 (1993), pp. 332-338
[7.]
K. Rappersberger, E. Tschachler, M. Tani, K. Wolff.
Bullous disease in systemic lupus erythematosus.
J Am Acad Dermatol, 21 (1989), pp. 745-752
[8.]
W.R. Gammon, D.T. Woodley, K.C. Dole, et al.
Evidence that anti-basement membrane zone antibodies in bullous eruption of systemic lupus erythematosus recognize epidermolysis bullosa acquisita autoantigen.
J Invest Dermatol, 84 (1985), pp. 472-476
[9.]
M. Chen, L.S. Chan, X. Cai, et al.
Development of an ELISA for rapid detection of anti-type VII collagen autoantibodies in epidermolysis bullosa acquisita.
J Invest Dermatol, 108 (1997), pp. 68-72
[10.]
J.A. Yell, J. Allen, F. Wojnarowska, et al.
Bullous systemic lupus erythematosus: revised criteria for diagnosis.
Br J Dermatol, 132 (1995), pp. 921-928
[11.]
R.P. Hall, T.J. Lawley, H.R. Smith, S.I. Katz.
Bullous eruption of systemic lupus erythematosus Dramatic response to dapsone therapy.
Ann Intern Med, 197 (1982), pp. 165-170
[12.]
L.S. Chan, J.C. Lapiere, M. Chen, et al.
Bullous systemic lupus erythematosus with autoantibodies recognizing multiple skin basement membrane components, bullous pemphigoid antigen 1, laminin-5, laminin- 6, and type VII collagen.
Arch Dermatol, 135 (1999), pp. 569-573
[13.]
J.A. Yell, F. Wojnarowska.
Bullous skin disease in lupus erythematosus.
Lupus, 6 (1997), pp. 112-121
[14.]
C. Camisa, H.M. Sharma.
Vesiculobullous systemic lupus erythematosus. Report of two cases and a review of the literature.
J Am Acad Dermatol, 9 (1983), pp. 924-933
[15.]
C. Camisa, R.E. Grimwood.
Indirect immunofluorescence in vesiculobullous eruption of systemic lupus erythematosus.
J Invest Dermatol, 86 (1986), pp. 606
[16.]
C. Camisa, Vesiculobullous systemic lupus erythematosus..
A report of four cases.
J Am Acad Dermatol, 18 (1988), pp. 93-100
[17.]
P. Bernard, L. Vaillant, B. Labeille, et al.
Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions.
Arch Dermatol, 131 (1995), pp. 48-52
[18.]
S. Vassileva.
Bullous systemic lupus erythematosus.
Clin Dermatol, 22 (2004), pp. 129-138
[19.]
S.N. Wong, S.H. Chua.
Spectrum of subepidermal immunobullous disorders seen at the National Skin Centre Singapore: a 2-year study.
Br J Dermatol, 147 (2002), pp. 476-480
[20.]
S. Jablonska, M. Blaszczyk.
Connective tissue diseases.
Women's dermatology: from infancy to maturity, pp. 205-217
[21.]
A.D. Dotson, S.S. Raimer, T.V. Pursley, et al.
Systemic lupus erythematosus occurring in a patient with epidermolysis bullosa acquisita.
Arch Dermatol, 117 (1981), pp. 422-426
[22.]
P.M. McHenry, J.H. Dagg, J.H. Tidman, et al.
Epidermolysis bullosa acquisita occurring in association with bullous lupus erythematosus.
Clin Exp Dermatol, 1993 (1991), pp. 378-380
[23.]
E. Boh, L.J. Roberts, T.S. Lieu, et al.
Epidermolysis bullosa acquisita preceding the development of systemic lupus erythematosus.
J Am Acad Dermatol, 22 (1990), pp. 587-593
[24.]
P.C. Don.
Vesiculobullous lupus erythematosus with milia formation.
Int J Dermatol, 31 (1992), pp. 793-795
[25.]
R. Prussick, A.K. Gupta.
Epidermolysis bullosa acquisita with features of bullous lupus erythematosus.
Int J Dermatol, 33 (1994), pp. 192-195
[26.]
J.A. Eckman, D.F. Mutasim.
Bullous systemic lupus erythematosus with milia and calcinosis.
Cutis, 70 (2002), pp. 31-34
[27.]
S. Miyagawa, Y. Shiomi, T. Fukumoto, et al.
Bullous eruption of systemic lupus erythematosus.
J Dermatol, 21 (1994), pp. 421-425
[28.]
G. Malcangi, G. Brandozzi, M. Giangiacomi, M. Zampetti, Mg. Danieli.
Bullous SLE: response to methotrexate and relationship with disease activity.
Lupus, 12 (2003), pp. 63-66
[29.]
Y.Y. Ng, T. Chang, T.W. Chen, H.N. Liou, A.H. Yang, W.C. Yang.
Concomitant lupus nephritis and bulous eruption in systemic lupus erythematosus.
Nephrol Dial Transplant, 14 (1999), pp. 1739-1743
[30.]
A. Lalova, K. Pramatarov, S. Vassileva.
Facial bullous systemic lupus erythematosus.
Int J Dermatol, 36 (1997), pp. 356-373
[31.]
T. Tsuchida, M. Furue, T. Kashiwado, et al.
Bullous systemic lupus erythematosus with cutaneous mucinosis and leukocytoclastic vasculitis.
J Am Acad Dermatol, 31 (1994), pp. 387-390
[32.]
A.N. Crowson, C. Magro.
The cutaneous pathology of lupus erythematosus: a review.
J Cutan Pathol, 28 (2001), pp. 1-23
[33.]
S. Vassileva.
Lupus erythematosus.
Diagnostic immunohistochemistry of the skin, pp. 144-156
[34.]
D. Woodley, D. Sauder, M.J. Talley, M. Silver, G. Grotendorst, E. Qwarnstrom.
Localization of basement membrane components after dermal-epidermal junction separation.
J Invest Dermatol, 81 (1983), pp. 149-153
[35.]
C.K. Janniger, C. Kowalewski, T. Mahmood, W.C. Lambert, R.A. Schwartz.
Detection of anti-basement membrane zone antibodies in bullous systemic lupus erythematosus.
J Am Acad Dermatol, 24 (1991), pp. 643-647
[36.]
D.D. Barton, J.D. Fine, W.R. Gammon, W.M. Sams Jr..
Bullous systemic lupus erythematosus: an unusual clinical course and detectable circulating autoantibodies to the epidermolysis bullosa acqusita antigen.
J Am Acad Dermatol, 15 (1986), pp. 369-373
[37.]
S. Shirahama, F. Furukawa, H. Yagi, T. Tanaka, T. Hashimoto, M. Takigawa.
Bullous systemic lupus erythematosus: detection of antibodies against noncollagenous domain of type VII collagen.
J Am Acad Dermatol, 38 (1998), pp. 844-848
[38.]
D.A. Jones, S.W. Hunt 3rd, P.S. Prisayanh, R.A. Briggaman, W.R. Gammon.
Immunodominant autoepitopes of type VII collagen are short, paired peptide sequences within the fibronectin type III homology region of the noncollagenous (NC1) domain.
J Invest Dermatol, 104 (1995), pp. 231-235
[39.]
M. Chen, M.P. Marinkovich, J.C. Jones, E.A. O’Toole, Y.Y. Li, D.T. Woodley.
NC1 domain of type VII collagen binds to the beta3 chain of laminin 5 via a unique subdomain within the fibronectin-like repeats.
J Invest Dermatol, 112 (1999), pp. 177-183
[40.]
W.R. Gammon.
Autoimmunity to collagen VII: autoantibody- mediated pathomechanisms regulate clinical-pathological phenotypes of acquired epidermolysis bullosa and bullous SLE.
J Cutan Pathol, 20 (1993), pp. 109-114
[41.]
M. Chen, D.R. Keene, F.K. Costa, et al.
The carboxyl terminus of type VII collagen mediates antiparallel dimer formation and constitutes a new antigenic epitope for epidermolysis bullosa acquisita autoantibodies.
J Biol Chem, 276 (2001), pp. 21649-21655
[42.]
W.R. Gammon, R.A. Briggaman, A.O. Inman III, C.C. Merritt, C.E. Wheeler Jr..
Evidence supporting a role for immune complex-mediated inflammation in the pathogenesis of bullous lesions of systemic lupus erythematosus.
J Invest Dermatol, 81 (1983), pp. 320-325
[43.]
W.R. Gammon, E.R. Heise, W.A. Burke, J.D. Fine, D.T. Woodley, R.A. Briggaman.
Increased frequency of HLA-DR2 in patients with autoantibodies to epidermolysis bullosa acquisita antigen Evidence that the expression of autoimmunity to type VII collagen is HLA class II allele associated.
J Invest Dermatol, 91 (1988), pp. 228-232
[44.]
N.J. Lance, W. Blaszak, T.J. Swartz.
Bullous skin lesions in systemic lupus erythematosus.
Sem Arthritis Rheum, 20 (1991), pp. 396-404
[45.]
M. Tani, R. Shimizu, M. Ban, Y. Murata, A. Tamaki.
Systemic lupus erythematosus with vesiculobullous lesions.
Arch Dermatol, 120 (1984), pp. 1497-1501
[46.]
A. Yung, A. Oakley.
Bullous systemic lupus erythematosus.
Australas J Dermatol, 41 (2000), pp. 234-237
[47.]
P. Patricio, C. Ferreira, M.M. Gomes, P. Filipe.
Autoimmune Bullous Dermatoses: A Review.
Ann NY Acad Sci, 1173 (2009), pp. 203-210
[48.]
A.J. Olansky, R.A. Briggaman, W.R. Gammon, T.F. Kelly, W.M. Sams Jr..
Bullous systemic lupus erythematosus.
J Am Acad Dermatol, 7 (1982), pp. 511-520
[49.]
R.A. Jacoby, A.A. Abraham.
Bullous dermatosis and systemic lupus erythematosus in a 15-year-old boy.
Arch Dermatol, 115 (1979), pp. 1094-1097
[50.]
A.H. Kettler, S.F. Bean, J.O. Duffy, W.R. Gammon.
Systemic lupus erythematosus presenting as a bullous eruption in a child.
Arch Dermatol, 124 (1988), pp. 1083-1087
Copyright © 2009. Asociación Colombiana de Reumatología
Download PDF
Article options